Published in

Springer Nature [academic journals on nature.com], British Journal of Cancer, 6(99), p. 974-977, 2008

DOI: 10.1038/sj.bjc.6604624

Links

Tools

Export citation

Search in Google Scholar

An evaluation of the polymorphisms Ins16bp and Arg72Pro in p53 as breast cancer risk modifiers in BRCA1 and BRCA2 mutation carriers

Journal article published in 2008 by M. Poll|[aacute]|n, A. Osorio, M. Pollan, M. Pollán ORCID, G. Pita, Rk K. Schmutzler, B. Versmold, C. Engel ORCID, Schmutzler Rk, A. Meindl, N. Arnold ORCID, D. Yannoukakos, A. Jakubowska, S. Preisler-Adams, U. Hamann and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

The close functional relationship between p53 and the breast cancer susceptibility genes BRCA1 and BRCA2 has promoted the investigation of various polymorphisms in the p53 gene as possible risk modifiers in BRCA1/2 mutation carriers. Specifically, two polymorphisms in p53, c.97-147ins16bp and p.Arg72Pro have been analysed as putative breast cancer susceptibility variants, and it has been recently reported that a p53 haplotype combining the absence of the 16-bp insertion and the presence of proline at codon 72 (No Ins-72Pro) was associated with an earlier age at the onset of the first primary tumour in BRCA2 mutation carriers in the Spanish population. In this study, we have evaluated this association in a series of 2932 BRCA1/2 mutation carriers from the Consortium of Investigators of Modifiers of BRCA1 and BRCA2.Keywords: BRCA1, BRCA2, p53, breast cancer